Book Hydroxychloroquine Eye Screening | Lahalak Medical Platform

Essential periodic screening for autoimmune patients on long-term hydroxychloroquine therapy. This comprehensive eye exam detects early retinal toxicity using advanced OCT and visual field tests to ensure your vision remains safe and protected.

Scientific name: Hydroxychloroquine (Plaquenil) Ocular Toxicity Screening

Comprehensive eye screening involving OCT and visual field testing. It monitors retinal health for patients on long-term hydroxychloroquine treatment to prevent irreversible vision loss through early detection and critical baseline assessment.

Hydroxychloroquine (Plaquenil) Ocular Toxicity Screening - Protect Your Vision During Plaquenil Therapy
Service type Medical Screening and Imaging
Duration 30-45 minutes
Fasting Fasting is not required

Included Services

  • Optical Coherence Tomography (OCT)
  • Automated Visual Field Test
  • Clinical Fundus Examination
  • Visual Acuity Testing

Medical Service Information

Why is this screening necessary?

  • Early detection of retinal toxicity before symptoms appear
  • Establishing a baseline before starting medication
  • Monitoring annual changes to protect the optic nerve
  • Preventing permanent vision loss from drug accumulation

Target Groups

  • Rheumatoid arthritis and Lupus patients on Hydroxychloroquine
  • Patients using the medication for more than 5 years
  • Individuals on high doses relative to body weight
  • Elderly patients or those with chronic kidney disease

Frequency of Screening

  • Baseline exam immediately upon starting therapy
  • Annual screening after 5 years of continuous use
  • Immediate annual screening if high-risk factors exist
  • Whenever sudden changes in vision or color perception occur

Conditions & Notices

  • Bring a report of your daily medication dosage
  • A companion is recommended if pupil-dilating drops are used